Diagnosing major depressive disorder: II: is there justification for compound symptom criteria?

J Nerv Ment Dis

Department of Psychiatry and Human Behavior, Brown University School of Medicine, Rhode Island Hospital, Providence, Rhode Island 02905, USA.

Published: April 2006

The DSM-IV symptom inclusion criteria for the diagnosis of major depressive disorder (MDD) are constructed in three ways: single symptom criteria, compound criteria encompassing opposite variants of the same disturbance, and compound criteria encompassing related problems. In the present report from the Rhode Island Methods to Improve Diagnostic Assessment and Services project, we tested the following three hypotheses: (1) the components of compound-opposite criteria rarely occur simultaneously, (2) the components of the compound-related criteria frequently occur simultaneously, and (3) the components of the compound-related criteria more frequently co-occur than other pairs of the MDD criteria. We also examined how many patients would be rediagnosed if the compound criteria were split into separate items. One thousand eight hundred psychiatric outpatients were evaluated with a semistructured diagnostic interview. We inquired about all of the DSM-IV diagnostic criteria for MDD for all patients. As hypothesized, the symptoms of the compound-opposite criteria usually did not co-occur, whereas the symptoms of the compound-related criteria frequently were present simultaneously. However, the results also indicated that other pairs of symptoms were as likely to co-occur, and were as strongly associated with each other, as the symptoms of the compound-related criteria. Thus, the findings provide mixed support for the assumptions hypothesized to underlie the composition of the DSM-IV criteria for MDD. When the compound criteria were subdivided and the diagnostic threshold for MDD was kept constant, only a small percentage of patients was reclassified from a noncase to a case. The implications of these results for constructing diagnostic criteria, and for developing measures to assess the severity of depression, are discussed.

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.nmd.0000207423.36765.89DOI Listing

Publication Analysis

Top Keywords

criteria
16
compound criteria
16
compound-related criteria
16
criteria frequently
12
major depressive
8
depressive disorder
8
criteria encompassing
8
compound-opposite criteria
8
occur simultaneously
8
simultaneously components
8

Similar Publications

The immunogenicity of rabies vaccines is commonly measured by serological testing, which includes measuring rabies virus-neutralising antibody titre levels in the serum. Apart from humoral immunity, cellular immunity measurements are also helpful in assessing the immunogenicity and efficacy of rabies vaccinations. Recently, there has been an increased emphasis on cellular immunity measurements against rabies in humans and animals.

View Article and Find Full Text PDF

Setting standards for brain collection procedures in metabolomic studies.

J Cereb Blood Flow Metab

January 2025

Department of Neurology and Department of Anatomy and Neurobiology, University of Tennessee Health Science Center, Memphis, Tennessee, USA.

Current metabolomics technologies can measure hundreds of chemical entities in tissue extracts with good reliability. However, long-recognized requirements to halt enzyme activities during the initial moments of sample preparation are usually overlooked, allowing marked postmortem shifts in levels of labile metabolites representing diverse pathways. In brain many such changes occur in a matter of seconds.

View Article and Find Full Text PDF

Study Objectives: This study assessed the utilization of potentially inappropriate medications (PIM) including oral sedative-hypnotic and atypical antipsychotic (OSHAA), healthcare resource utilization (HCRU), and costs among elderly individuals with insomnia and in the subpopulation with Alzheimer's Disease (AD) who also had a diagnosis of insomnia.

Methods: Using claims database containing International Classification of Diseases, 10th Revision (ICD-10) codes, the cohort included individuals aged ≥ 65 with incident insomnia (EI, N=152,969) and AD insomnia subpopulation (ADI, N=4,888). Proportion of patients utilizing atypical antipsychotics or oral sedative-hypnotic medications, namely z-drugs, benzodiazepines, doxepin, Dual Orexin Receptor Antagonists (DORAs), and melatonin agonists, were assessed.

View Article and Find Full Text PDF

Background And Objectives: Huge clinical and research gaps exist concerning the epidemiology, natural history, availability, and accessibility of care for sleep disorders in sub-Saharan Africa (SSA). This study aimed to profile the characteristics of patients referred for polysomnography and the frequencies of sleep disorders encountered at the new sleep laboratory in Dar es Salaam, Tanzania.

Materials And Methods: This retrospective hospital-based descriptive observational study was conducted at the Aga Khan Hospital Dar es Salaam.

View Article and Find Full Text PDF

Study Objectives: Both the (ICSD) and the sleep-wake disorders section of the (DSM) emphasize the importance of clinical judgment in distinguishing the normal from the pathological in sleep medicine. The fourth edition of the DSM (DSM-IV, 1994) introduced the clinical significance criterion (CSC) to standardize this judgment and enhance diagnostic reliability.

Methods: This review conducts a theoretical and historical content analysis of CSC presence, frequency, and formulation in the diagnostic criteria of sleep disorders.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!